AAAAAA

   
Results: 1-25 | 26-28 |
Results: 26-28/28
PARAMETERS AFFECTING THE DEVELOPMENT OF NON-HODGKINS-LYMPHOMA IN PATIENTS WITH SEVERE HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION RECEIVING ANTIRETROVIRAL THERAPY
Authors: PLUDA JM VENZON DJ TOSATO G LIETZAU J WYVILL K NELSON DL JAFFE ES KARP JE BRODER S YARCHOAN R
Citation: Jm. Pluda et al., PARAMETERS AFFECTING THE DEVELOPMENT OF NON-HODGKINS-LYMPHOMA IN PATIENTS WITH SEVERE HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION RECEIVING ANTIRETROVIRAL THERAPY, Journal of clinical oncology, 11(6), 1993, pp. 1099-1107
ASSOCIATION OF TORULOPSIS-GLABRATA INFECTIONS WITH FLUCONAZOLE PROPHYLAXIS IN NEUTROPENIC BONE-MARROW TRANSPLANT PATIENTS
Authors: WINGARD JR MERZ WG RINALDI MG MILLER CB KARP JE SARAL R
Citation: Jr. Wingard et al., ASSOCIATION OF TORULOPSIS-GLABRATA INFECTIONS WITH FLUCONAZOLE PROPHYLAXIS IN NEUTROPENIC BONE-MARROW TRANSPLANT PATIENTS, Antimicrobial agents and chemotherapy, 37(9), 1993, pp. 1847-1849
BRIEF INTENSIVE THERAPY FOR ADULT ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) - SUPERIORITY OF ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
Authors: GORE SD KARP JE MILLER CB BRAINE HL HUMPHREY RL KAUFMANN S TUCKER RA BURKE PJ
Citation: Sd. Gore et al., BRIEF INTENSIVE THERAPY FOR ADULT ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) - SUPERIORITY OF ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 82(10), 1993, pp. 10000056-10000056
Risultati: 1-25 | 26-28 |